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Abstract
Background: BAK (Bcl-2 homologous antagonist/killer) is a novel pro-apoptotic gene of the Bcl-
2 family. It has been reported that gastric tumors have reduced BAK levels when compared with
the normal mucosa. Moreover, mutations of the BAK gene have been identified in human
gastrointestinal cancers, suggesting that a perturbation of BAK-mediated apoptosis may contribute
to the pathogenesis of gastric cancer. In this study, we explored the therapeutic effects of gene
transfer mediated elevations in BAK expression on human gastric cancer cells in vitro.
Methods: Eukaryotic expression vector for the BAK gene was constructed and transferred into
gastric cancer cell lines, MKN-45 (wild-type p53) and MKN-28 (mutant-type p53). RT-PCR and
Western Blotting detected cellular BAK gene expression. Cell growth activities were detected by
MTT colorimetry and flow cytometry, while apoptosis was assayed by electronic microscopy and
TUNEL. Western Blotting and colorimetry investigated cellular caspase-3 activities.
Results: BAK gene transfer could result in significant BAK overexpression, decreased in vitro
growth, cell cycle G0/G1 arrest, and induced apoptosis in gastric cancer cells. In transferred cells,
inactive caspase-3 precursor was cleaved into the active subunits p20 and p17, during BAK
overexpression-induced apoptosis. In addition, this process occurred equally well in p53 wild-type
(MKN-45), or in p53 mutant-type (MKN-28) gastric cancer cells.
Conclusions: The data presented suggests that overexpression of the BAK gene can lead to
apoptosis of gastric cancer cells in vitro, which does not appear to be dependent on p53 status. The
action mechanism of BAK mediated apoptosis correlates with activation of caspase-3. This could
be served as a potential strategy for further development of gastric cancer therapies.
Background
Apoptosis is critical, not only for tissue homeostasis, but
also in the pathogenesis of a variety of diseases, including
cancer. The transformation of gastrointestinal epithelial
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tissue to carcinomas has been shown to be associated with
the progressive inhibition of apoptosis [1,2]. The Bcl-2
family of genes appears to be important in the regulation
of apoptosis. Members of this family are cellular homo-
logues that are either pro-apoptotic (Bax, Bik and Bid) or
anti-apoptotic (Bcl-2 and Bcl-XL) [3,4]. Recently, BAK (a
Bcl-2 homologous antagonist/killer) has been cloned as a
Bcl-2-related gene [5,6]. The BAK gene encodes a 211-
amino acid protein with a relative molecular weight (Mr)
of 23,400. Gene transfer mediated elevations in BAK pro-
tein levels accelerate apoptosis induced by growth factor
deprivation in murine lymphoid, lung cancer and breast
cancer cells [7], suggesting that BAK functions primarily as
a promoter of apoptosis.
BAK expression has been reported in normal gastrointes-
tinal epithelium [8]. Strong BAK immunoreactivity has
been shown to be present in the gastric epithelial cells lin-
ing the gastric pits and parietal cells, whereas the self-
renewing mucous cells located below the gastric pits in the
gastric neck region are immunonegative [9]. In gastroin-
testinal epithelial tissues, the up-regulation of BAK expres-
sion during differentiation may help to ensure that cell
turnover occurs in a normal fashion. However, it has been
reported that gastric tumors have reduced BAK levels
when compared with the normal mucosa [10]. Moreover,
mutations of the BAK gene have been identified in human
gastrointestinal cancers, suggesting that a perturbation of
BAK-mediated apoptosis may contribute to the pathogen-
esis of gastric cancer [11,12].
Several recent reports have demonstrated the feasibility of
using gene transfers to treat gastric cancers [13,14]. In the
current study, utilizing BAK gene transfer via plasmid vec-
tor, we investigated the apoptosis inducing effects of BAK
overexpression on human gastric cancer cells in vitro, in
order to explore a novel strategy for gene therapy of gastric
cancer.
Methods
Cell lines and reagents
The human gastric cancer cell lines, MKN-45 (wild-type
p53) and MKN-28 (mutant type p53), were obtained
from the Typical Culture Center of Wuhan University
(China). Cells were maintained at 37°C in a humidified
atmosphere of 5% CO2 in RPMI 1640 (Gibco PRL) sup-
plemented with penicillin/streptomycin (100 units/ml
and 100 µg/ml, respectively) and 10% fetal calf serum
(FCS). Restriction enzymes and DNA recovery kits were
purchased from Promega Company. T4 DNA Ligase was
purchased from the TaKaRa company. Propidium iodide
was purchased from the Sigma company. TUNEL and cas-
pase-3 activity detection kits were purchased from the
Boster and Clontech companies respectively.
Vector construction
Plasmid pET-BAK was kindly provided by Dr. Patty Wen-
del (Cold Spring Harbour, USA), which contained the
BAK cDNA (633 bp) between the restriction sites for XhoI
and HindIII. Prof. Shen Qu (Department of Biochemistry,
Tongji Medical College, China) provided the eukaryotic
vector pcDNA3. XhoI and Hind III digested the plasmids,
pET-BAK and pcDNA3, to recover the BAK gene (633 bp)
and linear vector fragments (5.4 Kb) respectively. The liga-
tion reaction was conducted with T4 Ligase. According to
the physical maps of both the BAK gene and vector, XhoI,
HindIII,  XhoI  and  HindIII  digested the recombinant
respectively, for restrictive enzyme reaction assay.
Gene transfer and expression
For both MKN-45 and MKN-28 cell lines, untransfer con-
trol, pcDNA3  and pcDNA-BAK transfer groups were
designed. Gene transfer was conducted with Lipo-
fectamine 2000 (Gibco company, USA), according to the
suggestion of the manufacturer. Cellular BAK mRNA
expression levels were assayed by reverse transcription
polymerase chain reaction (RT-PCR). Cellular total RNA
extraction was conducted with TRIzol (Life Technologies
company). After the reverse transcription reaction, PCR
amplification reaction was conducted with the following
primers: BAK (502 bp) upstream 5'-CTGCCCT CTGCT-
TCTGA-3', downstream 5'-CGTT CAGGATGGGACCA-3'.
α-Tubulin (295 bp) upstream 5'-CCCGTCTTCAG-
GGTCTCTTG-3', downstream 5'-TTAAGGTAAGTGTAG-
GTTGGG-3'. α-Tubulin served as an internal control for
PCR. Amplification products were separated with 1% aga-
rose electrophoresis and observed under ultraviolet light.
The brightness ratios between BAK and α-Tubulin were
evaluated with gel computer image system (Gel Doc 1000,
Bio-Rad company). Cellular BAK protein expression levels
were assayed via Western Blotting. The extraction, quanti-
fication and separation of proteins were conducted
according to Molecular Cloning. Blots were incubated
sequentially with 1% nonfat dry milk, mouse monoclonal
anti-BAK antibody (Boster Company) and goat radish
peroxidase-conjugated antimouse immunoglobulin G,
and evaluated using an ECL Western blotting kit. α-Tubu-
lin served as an internal control for the immunoblot. Pro-
tein band intensities were determined densitometrically
using the Computer Imaging System.
Cellular growth assay
The MKN-45 and MKN-28 cells were seeded at 3 × 104/ml
density in 96-well chamber slides (each group had five
wells). After transferring for 1d, 3d and 5d, cellular growth
was detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-dimeth-
yltetrazolium bromide (MTT, Clontech) colorimetric
method. Each well was given 20 µl of 0.5% MTT and cul-
tured for another 4 h. The supernatant was discarded, then
the pellet was given 100 µl of dimethyl sulfoxide. WhenBMC Cancer 2004, 4:33 http://www.biomedcentral.com/1471-2407/4/33
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the crystal dissolved, the optical density A values of the
slides were read on an enzyme-labeled Minireader II at
570 nm. Cellular proliferation inhibition rates are calcu-
lated as (%) = (1-average A570nm value of experimental
group/average A570nm value of untransfer control group) ×
100%.
Cell cycle assay
After transferring for 3d, 2 × 106 cells from the above
groups were collected. Cells were washed twice with 0.01
mol/L phosphate-buffer saline (PBS) and fixed in 70%
ethanol overnight at 4°C. Then the cells were washed
once with PBS, digested by 200 µl RNase (1 mg/ml) at
37°C for 30 minutes, and stained with 800 µl propidium
iodide (50 µg/ml) at room temperature for 30 minutes.
The DNA histograms were assayed by flow cytometry
(Becton Dickson company) and analyzed with CELLQEST
software.
Cellular apoptosis detection
Cancer cells from the groups above were collected, rinsed
by PBS, fixed using 2.5% glutaraldehyde for 30 minutes,
and then washed with PBS. After routine embedment and
slicing, cellular ultrastructure was observed under an elec-
tronic microscope. The TdT-mediated dUTP-biotin nick
end labeling (TUNEL) method detected the apoptotic
rates. After blocking with 0.3% H2O2 for 30 min, slices
were digested by Proteinase K (20 mg/L) for 20 min, then
incubated with the TUNEL reaction solution at 37°C for
60 min. Then, the slices were incubated with peroxidase-
conjugated antibody at 37°C for 30 min, stained with
diaminobenzidine (DAB) and counterstained using hae-
matoxylin. Instead of the TUNEL reaction solution, PBS
was used as a negative control. Under a light microscope,
the volume of the apoptotic cells became smaller, with
shrinking nuclei and a specific palm-yellow color in the
chromosome.
Caspase-3 expression and activities assays
Cellular caspase-3 protein expression determinations
came from Western Blotting (as the same method above).
2 × 105 cells from above groups were collected, 50 µl of
cellular lysis buffer was added, and then they were incu-
bated on ice for 10 min. After centrifugation (12000 rpm)
at 4°C for 3 min, the supernatant was collected and added
sequentially with 50 µl 2 × Reaction Buffer, 5 µl 1.0
mmol/L caspase-3 substrate DEVD-pNA, and incubated at
37°C for 1 h. After being transferred into 96 wells, the
optical density A values of the slides were read on enzyme-
labeled Minireader II at the wave length of 405 nm (A405
nm), which is the relative activities of caspase-3.
Statistical analysis
Data analysis was performed using SPSS 10.0 statistical
software.
Results
BAK overexpression in gastric cancer cells
The eukaryotic expression vector, pcDNA-BAK (6.0 Kb),
was constructed. Electrophoresis, on a 1% agarose gel,
showed the BAK cDNA insertion reactions into the recom-
binant were successful (Fig. 1A). After electrophoresis of
RT-PCR products, BAK amplification bands could be
observed in both untransfer and pcDNA3 transfer groups.
The difference between them is not significant (P>0.05).
After transferring with pcDNA-BAK for 3d, BAK mRNA
levels in MKN-45 and MKN-28 cells were significantly
increased (P<0.01) (Fig. 1B). Western Blotting and densi-
tometric analysis indicated BAK protein bands brightness
of pcDNA-BAK transferred MKN-45 and MKN-28 cells
were significantly higher than those of untransferred and
pcDNA3 transferred cells respectively (P<0.01) (Fig. 1C).
Cellular growth inhibition
In untransfer control group, the A570nm  values were
increased with the incubation time, indicating the active
in vitro growth of MKN-45 and MKN-28 cells. After trans-
ferring with pcDNA-BAK for 1d~5d, the growth activities
of MKN-45 and MKN-28 cells were both reduced to varia-
ble extents, with their inhibitory rates being
10.25%~32.41% (P<0.01), 11.54%~33.45% (P<0.01),
respectively (Fig. 2).
Cell cycle arrest
On histograms of flow cytometry (Fig. 3), the S phase
ratio in pcDNA-BAK transferred cancer cells was signifi-
cantly lower than that of untransferred control, while cell
cycles were arrested at the G0/G1 phase. In both pcDNA-
BAK transferred MKN-45 and MKN-28 cells, sub-diploid
DNA peak, corresponding to the apoptotic cell fraction,
could be detected.
Cellular apoptosis induced
After transferring with pcDNA-BAK, parietal MKN-45 and
MKN-28 presented characteristic morphological changes
of apoptosis, such as nuclear shrinking, chromatin con-
gregating around the nuclear membrane, reduction of cell
volume and integrity of nuclear membrane, which could
be viewed under an electronic microscope (Fig. 4A). The
TUNEL assay indicated that the apoptosis rates of untrans-
ferred MKN-45 and MKN-28 cells were 4.7%, 4.2%
respectively after being cultured for 3d. After pcDNA-BAK
transfer for 3d, the apoptosis rates of MKN-45 and MKN-
28 cells were 21.4%, 20.1% respectively (P<0.01). (Fig.
4B).
Caspase-3 activities increase
After pcDNA-BAK transfer, the 20 k Da (p20) and 17 k Da
(p17) protein bands, subunits of caspase-3, could be
detected in MKN-45 and MKN-28 cells (Fig. 5A). The A405
nm values in untransferred MKN-45 and MKN-28 cellsBMC Cancer 2004, 4:33 http://www.biomedcentral.com/1471-2407/4/33
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were 0.055 ± 0.008, 0.045 ± 0.010 respectively. After
transferring with pcDNA-BAK for 3d, their cellular A405 nm
value were increased to 0.245 ± 0.012 (P<0.01), 0.238 ±
0.011 (P<0.01) (Fig. 5B).
Discussion
Gastric cancer is the most common malignant tumor of
the gastrointestinal tract in the world. There has been a
clinical need to identify ideal candidate genes for use in
treating gastric cancer patients with gene transfer strategies
[15]. One promising group is the pro-apoptotic members
of the Bcl-2 family (Bax and BAK), which have been
shown to induce apoptosis after gene transfer via plasmid
vectors in vivo [16,17].
The pro-apoptotic BAK gene is located on chromosome 6
and shares homology with the entire Bcl-2 family,
including the anti-apoptotic and pro-apoptotic members
[18]. In fact, the family members interact through highly
conserved areas of Bcl-2 homology (BH1, BH2, and BH3)
that allow hetero- and homodimerization and the conse-
quent close regulation of apoptosis [19]. In the case of
Bax, this scheme has been well worked out in a rheostat
model in which excess pro-apoptotic Bax suppresses Bcl-2
and induces apoptosis via cytochrome c  [20]. Less is
known about BAK, but there is evidence that BAK can
form heterogenous dimers with Bcl-2 or Bcl-xL to inhibit
their anti-apoptotic functions [21]. The deficiency in BAK
was directly responsible for the arrest in cytochrome c
release. This capability was restored to the BAK-deficient
cells by the insertion of recombinant BAK into purified
mitochondria from these cells [22]. Furthermore, syner-
gistic activity was detected in the presence of combina-
tions of suboptimal doses of recombinant BAK and Bax,
suggesting, that in the presence of a low dose of recom-
binant BAK, the resistance of these mitochondria to Bax-
mediated cytochrome c  release was reversed [23]. As
recently reported for hepatocytes from BAK-/- mice [24],
BAK-deficient Jurkat cells were also resistant to tBid induc-
tion of cytochrome c  release, suggesting that in these
leukemic cells, BAK is involved in mitochondrial cyto-
chrome c release induced by either tBid or Bax.
BAK gene overexpression mediated by gene transfer Figure 1
BAK gene overexpression mediated by gene transfer. 
A, Restrictive enzyme reaction assay after recombinant 
pcDNA-BAK digested with Xho I+Hind III (Lane 2); Hind III 
(Lane 3); Xho I (Lane 4); The blank pcDNA-BAK (Lane 5) and 
DNA marker λ DNA/Hind III + EcoR I (Lane 1) were used as 
controls. B, Reverse transcription polymerase chain reaction 
assay of BAK mRNA levels in untransferred (Lane 1), 
pcDNA3 transferred (Lane 2) and pcDNA-BAK transferred 
(Lane 3) gastric cancer cells. The expression level of α-Tubu-
lin was used as a control. C, Western Blotting analysis of 
BAK protein levels in untransferred (Lane 3), pcDNA3 trans-
ferred (Lane 2) and pcDNA-BAK transferred (Lane 1) gastric 
cancer cells. The expression level of α-Tubulin was used as a 
control.
Growth inhibition effects of BAK overexpression on gastric  cancer cells Figure 2
Growth inhibition effects of BAK overexpression on 
gastric cancer cells. MTT assay after MKN-45 and MKN-
28 cells were transferred with blank pcDNA3 and pcDNA-
BAK vectors for 1d, 3d and 5d.BMC Cancer 2004, 4:33 http://www.biomedcentral.com/1471-2407/4/33
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Current evidence indicated that deficiency of BAK expres-
sion is closely correlated with occurrence and develop-
ment of tumors [25]. Tomkova et al investigated the BAK
expression in twenty cases of neoplastic skin diseases.
They found seventeen were negative for immunostaining,
and the other three cases showed only weak immunos-
taining in the regions of tumor formation [26]. Kondo et
al found that positive ratios of BAK expression were nega-
tively correlated with the pathological stages and clinical
phases of gastric cancer [27]. Many kinds of tumor thera-
peutic drugs, such as perillyl alcohol and γ-interferon,
function through up-regulating BAK expression [28].
Recently, Pataer et al reported that adenoviral-mediated
overexpression of BAK could induce obvious apoptosis in
lung and breast cancer cells, which provided a novel ther-
apeutic strategy for cancer therapy [29].
In the present study, high levels of BAK protein were
induced in gastric cancer cell line MKN-45 and MKN-28
(Fig. 1B,1C). It was also indicated that BAK overexpres-
sion could arrest the cell cycle (Fig. 2B) and induce apop-
tosis in cancer cells (Fig. 3A,3B). Current evidence
indicated that the caspases, which are cysteine proteases
of the ICE/CED-3 family, are the central components of
the cell death machinery in various forms of apoptosis. Of
course, caspase-3 is the most likely candidate for a mam-
malian cell death regulator by cleaving vital cellular
proteins [30]. In this study, we found that the inactive cas-
pase-3 precursor was cleaved into the 20 kDa and 17 kDa
subunits, forming the active protease during BAK overex-
pression-induced apoptosis (Fig. 4A,4B). In addition, our
studies suggest that this process is p53 independent
because BAK-induced apoptosis occurred equally well in
Cell cycle arrest effects of BAK overexpression on gastric cancer cells Figure 3
Cell cycle arrest effects of BAK overexpression on gastric cancer cells. Cell cycle analysis after MKN-45 and MKN-28 
cells were transferred with blank pcDNA3 (Lane 2) and pcDNA-BAK (Lane 3) vectors for 3d, with untransferred cancer cells 
as controls (Lane 1). Sub-diploid peaks could be detected in both pcDNA-BAK transferred MKN-45 and MKN-28 cells.BMC Cancer 2004, 4:33 http://www.biomedcentral.com/1471-2407/4/33
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p53 wild-type (MKN-45) or p53 mutant-type (MKN-28)
cells. This observation may be explained by the fact that
the Bcl-2 family members function downstream from p53
in the apoptotic cascade. Then the clinical use of the BAK
vector may be independent of p53. If so, then the treat-
ment of p53 mutant or resistant cancer cells with BAK
gene transfer might be possible.
Conclusions
The data presented in this paper show for the first time
that overexpression of BAK, mediated by plasmid vectors,
leads to apoptosis of gastric cancer cells in vitro. This anti-
cancer strategy does not appear to be dependent on p53
status. The action mechanism of BAK mediated apoptosis,
however, correlates with activation of caspase-3. Consist-
ent with other finding in BAK genes, we believe BAK plays
a pivotal role in the process of apoptosis. This serves as a
Apoptosis inducing effects of BAK overexpression on gastric cancer cells Figure 4
Apoptosis inducing effects of BAK overexpression on gastric cancer cells. A, Morphological observation of gastric 
cancer cells under electronic microscope:   Normal cells in untransferred group;   Chromatin congregating around nuclear 
membrane in pcDNA-BAK transferred cancer cells;   Nucleus shrinking in pcDNA-BAK transferred cancer cells. B, Apopto-
sis detection by TUNEL:   There were no obvious apoptotic cells in the untransferred group;   The pcDNA-BAK trans-
ferred cells reduced in size with obvious nuclear staining.
c d
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potential target for further therapeutic development of
gastric cancer.
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